Zobrazeno 1 - 10
of 19
pro vyhledávání: '"TS Choy"'
Autor:
S Y Yeung, Ka-On Lam, K S Lau, H C Choi, S F Lee, K K Yuen, Siok-Yee Chan, Chi-Leung Chiang, B Y Chan, TS Choy
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 15:5-13
AIM To investigate treatment patterns and outcomes of metastatic colorectal cancer (mCRC) patients beyond second progression (PD2) since regorafenib and TAS-102 became available in Hong Kong. METHODS The clinical records of consecutive mCRC patients
Autor:
Ka-On Lam, Keith Wan-Hang Chiu, Victor Ho-Fun Lee, TS Choy, Gavin T. C. Cheung, H An, Johnny Kin Sang Lau
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Background 18F-FDG PET-CT is commonly used to monitor treatment response in patients with metastatic colorectal cancer (mCRC). With improvement in systemic therapy, complete metabolic response (CMR) is increasingly encountered but its clinical signif
Autor:
Dennis Kc Leung, Dicky Or, TS Choy, Victor Lee, Kin-Sang Lau, To-Wai Leung, Ka-On Lam, Tsz-Yui Yau, Cheuk-Wai Choi
Publikováno v:
Journal of Clinical Oncology. 35:e20521-e20521
e20521 Background: First and second generation TKI (gefitinib, erlotinib, afatinib) is the standard 1st line therapy for EGFR-mutated metastatic NSCLC. Resistance ultimately develops despite initial durable response. Oligometastasis (OM) (defined as
Autor:
To-Wai Leung, TS Choy, Victor Ho-Fun Lee, Elaine Yuen Phin Lee, Dora L.W. Kwong, Patty Pui-Ying Ho, Pek-Lan Khong, Dennis K.C. Leung, Wendy W L Chan, Ka-On Lam
Publikováno v:
American journal of clinical oncology. 39(4)
OBJECTIVES Definitive concurrent chemoradiotherapy is the standard treatment for stage III non-small cell lung cancer (NSCLC). Previous studies showed that the tumor size and its metabolic activity are predictors of treatment outcome. We investigated
Autor:
Maria Pik Wong, TS Choy, Patty Pui-Ying Ho, Janice W.H. Tsang, Jing Liu, To-Wai Leung, Victor Ho-Fun Lee, Edmond S. K. Ma, Dennis K.C. Leung, Vicky Pui-Chi Tin, Cheuk-Wai Choi, Ka-On Lam, Tony W. H. Shek, Lap-Ping Chung, Dora L.W. Kwong
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 8(9)
Background: This study investigated whether there were differential survival outcomes to first-line tyrosine kinase inhibitors (TKI) in patients with metastatic non–small-cell lung cancer harboring different subtypes of exon 19 and exon 21 mutation
Publikováno v:
Annals of Oncology. 26:ix42
Autor:
To-Wai Leung, Dora L.W. Kwong, Dennis K.C. Leung, Ka-On Lam, Pui-Mei Lam, TS Choy, Victor Ho-Fun Lee
Publikováno v:
BMC Cancer
Afaitnib has shown anti-tumor activity against metastatic EGFR-mutated NSCLC after prior failure to first generation EGFR-TKI and chemotherapy. We prospectively evaluated the efficacy and safety of afatinib in Chinese patients who previously failed f
Autor:
Chiang CL; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China., Choi HC; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Lam KO; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.; Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China., Chan BY; Department of Clinical Oncology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China., Lee SF; Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, China., Yeung SY; Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong, China., Lau KS; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China., Chan SY; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China., Choy TS; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China., Yuen KK; Department of Clinical Oncology, Queen Mary Hospital, Hong Kong, China.
Publikováno v:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2019 Mar; Vol. 15 Suppl 2, pp. 5-13. Date of Electronic Publication: 2019 Mar 19.
Autor:
Chiu KWH; Department of Diagnostic Radiology, LKS Faculty of Medicine, The University of Hong Kong, 102, Pokfulam Raod, Hong Kong, China., Lam KO; Department of Clinical Oncology, LKS Faculty of Medicine, The University of Hong Kong, 1/F Professorial Block, 102, Pokfulam Raod, Hong Kong, China. lamkaon@hku.hk.; Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, 102, Pokfulam Raod, Hong Kong, China. lamkaon@hku.hk., An H; Department of Diagnostic Radiology, LKS Faculty of Medicine, The University of Hong Kong, 102, Pokfulam Raod, Hong Kong, China., Cheung GTC; Department of Clinical Oncology, Queen Elizabeth Hospital, 30 Gascoigne Raod, Hong Kong, China., Lau JKS; Department of Clinical Oncology, Queen Mary Hospital, 1/F Professorial Block, 102, Pokfulam Raod, Hong Kong, China., Choy TS; Department of Clinical Oncology, Queen Mary Hospital, 1/F Professorial Block, 102, Pokfulam Raod, Hong Kong, China., Lee VHF; Department of Clinical Oncology, LKS Faculty of Medicine, The University of Hong Kong, 1/F Professorial Block, 102, Pokfulam Raod, Hong Kong, China.; Clinical Oncology Center, The University of Hong Kong-Shenzhen Hospital, 102, Pokfulam Raod, Hong Kong, China.
Publikováno v:
BMC cancer [BMC Cancer] 2018 Jul 31; Vol. 18 (1), pp. 776. Date of Electronic Publication: 2018 Jul 31.
Autor:
Lam KO; Department of Clinical Oncology, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong., Lee KC; Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong., Chiu J; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong., Lee VH; Department of Clinical Oncology, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong., Leung R; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong., Choy TS; Department of Clinical Oncology, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong., Yau T; Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong.
Publikováno v:
Postgraduate medical journal [Postgrad Med J] 2017 Jul; Vol. 93 (1101), pp. 395-400. Date of Electronic Publication: 2016 Nov 11.